650 related articles for article (PubMed ID: 7661275)
1. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
Lajoie G; Kumar S; Min KW; Silva FG
Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
[TBL] [Abstract][Full Text] [Related]
2. [Acute renal failure due to thrombotic microangiopathy associated with Castleman's disease].
López Montes A; Andrés Mompeán E; Martínez Villaescusa M; Llamas Fuente F; García-Mauriño Guelbenzu ML
An Med Interna; 2007 Dec; 24(12):591-4. PubMed ID: 18278998
[TBL] [Abstract][Full Text] [Related]
3. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
[TBL] [Abstract][Full Text] [Related]
4. Membranoproliferative glomerulonephritis associated with multicentric angiofollicular lymph node hyperplasia. Case report and review of the literature.
Said R; Tarawneh M
Am J Nephrol; 1992; 12(6):466-70. PubMed ID: 1292348
[TBL] [Abstract][Full Text] [Related]
5. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
[TBL] [Abstract][Full Text] [Related]
6. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
Seida A; Wada J; Morita Y; Baba M; Eguchi J; Nishimoto N; Okino T; Ichimura K; Yoshino T; Makino H
Am J Kidney Dis; 2004 Jan; 43(1):E3-9. PubMed ID: 14712466
[TBL] [Abstract][Full Text] [Related]
7. Severe polyneuropathy: initial manifestation of Castleman's disease associated with POEMS syndrome.
Ku A; Lachmann E; Tunkel R; Nagler W
Arch Phys Med Rehabil; 1995 Jul; 76(7):692-4. PubMed ID: 7605193
[TBL] [Abstract][Full Text] [Related]
8. Intestinal lymphangiectasia associated with angiofollicular lymph node hyperplasia (Castleman's disease).
Moss SF; Thomas DM; Mulnier C; McGill IG; Hodgson HJ
Gut; 1992 Jan; 33(1):135-7. PubMed ID: 1740268
[TBL] [Abstract][Full Text] [Related]
9. Rapidly progressive renal failure associated with angiofollicular lymph node hyperplasia.
Tsukamoto Y; Hanada N; Nomura Y; Hiki Y; Kasai K; Shigematsu H; Kobayashi Y
Am J Nephrol; 1991; 11(5):430-6. PubMed ID: 1809043
[TBL] [Abstract][Full Text] [Related]
10. A rare case of renal thrombotic microangiopathy associated with Castleman's disease.
Mutneja A; Cossey LN; Liapis H; Chen YM
BMC Nephrol; 2017 Feb; 18(1):57. PubMed ID: 28183278
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
12. Castleman's disease associated with pemphigus vulgaris.
Gili A; Ngan BY; Lester R
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):955-9. PubMed ID: 1761779
[TBL] [Abstract][Full Text] [Related]
13. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease).
Montoli A; Minola E; Stabile F; Grillo C; Radaelli L; Spanti D; Luccarelli E; Spata C; Minetti L
Am J Nephrol; 1995; 15(2):142-6. PubMed ID: 7733151
[TBL] [Abstract][Full Text] [Related]
14. Fibrillary glomerulonephritis in Castleman's disease.
Miadonna A; Salmaso C; Palazzi P; Elli A; Braidotti P; Lambertenghi Deliliers G
Leuk Lymphoma; 1998 Jan; 28(3-4):429-35. PubMed ID: 9517516
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic multicentric Castleman's disease: a systematic literature review.
Liu AY; Nabel CS; Finkelman BS; Ruth JR; Kurzrock R; van Rhee F; Krymskaya VP; Kelleher D; Rubenstein AH; Fajgenbaum DC
Lancet Haematol; 2016 Apr; 3(4):e163-75. PubMed ID: 27063975
[TBL] [Abstract][Full Text] [Related]
16. Castleman's disease of the neck.
Chen CC; Jiang RS; Chou G; Wang CP
J Chin Med Assoc; 2007 Dec; 70(12):556-8. PubMed ID: 18194898
[TBL] [Abstract][Full Text] [Related]
17. A benign course of multicentric Castleman's disease with involvement of the spleen and bone marrow.
Levo Y; Behar AJ; Blum I; Frish B
Eur J Haematol; 1987 Nov; 39(5):471-4. PubMed ID: 3691764
[TBL] [Abstract][Full Text] [Related]
18. Castleman's disease associated with myasthenia gravis.
Day JR; Bew D; Ali M; Dina R; Smith PL
Ann Thorac Surg; 2003 May; 75(5):1648-50. PubMed ID: 12735602
[TBL] [Abstract][Full Text] [Related]
19. Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease.
Sun PP; Yu XJ; Wang SX; Zhou XJ; Qu L; Zhang F; Ma YY; Liu G; Yang L
Nephrology (Carlton); 2020 Feb; 25(2):125-134. PubMed ID: 31264312
[TBL] [Abstract][Full Text] [Related]
20. [Transitional type of Castleman's disease manifested as the POEMS syndrome].
Tomić I; Plavec G; Tasić O; Ristanović A; Cvijanović V
Vojnosanit Pregl; 2004; 61(4):439-44. PubMed ID: 15552541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
